questionText: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure adequate availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other Attention Deficit Hyperactivity Disorder medication within (i) NHS Wales and (ii) Cwm Taf Morgannwg Health Board.
answerText: Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working ...
heading: Attention Deficit Hyperactivity Disorder: Wales